New congressional bill would thwart patent thickets

A new bill has been introduced in Congress to lower the cost of medicines by making it harder for pharmaceutical companies to use numerous patents to prevent generic competition. This legislation addresses patent thickets, a tactic used by drug companies to obtain numerous patents to protect their monopoly. The controversy has grown as brand-name companies collect more patents, making it difficult for generic rivals to defend against infringement claims. This has led to longer lawsuits and delayed launches of generic drugs. The bill aims to address this issue and make it easier for generic drugs to enter the market, ultimately reducing the cost of medicines.

Source link

error: Content is protected !!